Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 48,822,080
- Share change
- +5,348,724
- Total reported value
- $116,683,910
- Put/Call ratio
- 0%
- Price per share
- $2.39
- Number of holders
- 53
- Value change
- +$12,840,858
- Number of buys
- 37
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
8.9%
|
11,370,376
|
$21,035,196 | — | 31 Mar 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5.2%
|
6,663,590
|
$12,327,642 | — | 31 Mar 2023 | |
| Fairmount Funds Management LLC |
13F
|
Company |
4.4%
|
5,696,515
|
$10,538,553 | — | 31 Mar 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
4.4%
|
5,684,420
|
$10,516,177 | — | 31 Mar 2023 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
3.4%
|
4,400,000
|
$8,140,000 | — | 31 Mar 2023 | |
| TPG GP A, LLC |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
3,824,883
|
$7,726,264 | — | 01 Jul 2022 | |
| VR Adviser, LLC |
13F
|
Company |
2.4%
|
3,050,022
|
$5,642,541 | — | 31 Mar 2023 | |
| MAI Capital Management |
13F
|
Company |
1.2%
|
1,600,415
|
$2,960,768 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,499,751
|
$2,774,540 | — | 31 Mar 2023 | |
| Peter W. Sonsini |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
3,948,948
mixed-class rows
|
$1,916,875 | — | 11 Apr 2022 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
885,924
|
$1,638,959 | — | 31 Mar 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.65%
|
835,800
|
$1,546,230 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
248,293
|
$459,342 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
237,400
|
$439,000 | — | 31 Mar 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
0.15%
|
190,218
|
$351,903 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
188,400
|
$348,540 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
99,542
|
$184,153 | — | 31 Mar 2023 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.07%
|
93,500
|
$172,975 | — | 31 Mar 2023 | |
| J. Goldman & Co LP |
13F
|
Company |
0.07%
|
89,188
|
$164,998 | — | 31 Mar 2023 | |
| INNOVIS ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
87,369
|
$161,633 | — | 31 Mar 2023 | |
| TRUST CO OF TOLEDO NA /OH/ |
13F
|
Company |
0.06%
|
83,000
|
$153,550 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
82,245
|
$152,154 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
71,655
|
$132,562 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
64,183
|
$118,739 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
59,628
|
$110,000 | — | 31 Mar 2023 | |
| Atom Investors LP |
13F
|
Company |
0.03%
|
34,471
|
$63,771 | — | 31 Mar 2023 | |
| UNITED BANK |
13F
|
Company |
0.02%
|
28,450
|
$52,633 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
27,666
|
$51,182 | — | 31 Mar 2023 | |
| BAILARD, INC. |
13F
|
Company |
0.02%
|
21,200
|
$39,220 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
14,098
|
$26,081 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
12,928
|
$23,917 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
12,557
|
$23,230 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
11,474
|
$21,227 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$18,500 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,580
|
$14,023 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
384
|
$710 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
265
|
$490 | — | 31 Mar 2023 | |
| William P. Forbes |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
185,500
mixed-class rows
|
— | — | 29 Jun 2022 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q2 2023
As of 30 Jun 2023,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,822,080 shares.
The largest 10 holders included
NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, Fairmount Funds Management LLC, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, BlackRock Inc., VANGUARD GROUP INC, Opaleye Management Inc., and MAI Capital Management.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
35
Q2 2023 holders
53
Holder diff
18
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.